Interaction between the HPV-16 E2 transcriptional activator and p53
- 16 December 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (54) , 7748-7754
- https://doi.org/10.1038/sj.onc.1203208
Abstract
The HPV-16 E2 protein is a major regulator of viral DNA replication and gene expression. Through interactions with the viral origin binding protein, E1, it localizes E1 to the origin of replication and stimulates the initiation of viral DNA replication. However, several recent reports have described a number of diverse activities of E2 relating to the induction of apoptosis through both p53 dependent and independent mechanisms, and to induction of growth arrest in both the G1 and G2M phases of the cell cycle. Recent studies have also shown that p53 can specifically inhibit HPV DNA replication, albeit through an unknown mechanism. Since p53 has been described in the replication centres of Herpes Viruses, Adenovirus and SV40 we decided to investigate whether any of the above activities of E2 may be related to an association with p53. We show, in a series of in vitro assays, specific interaction between p53 and HPV-16 E2 via residues in the carboxy terminal half of the E2 protein. Mutational analysis of p53 indicates that sequences in both the DNA binding and oligomerization domains are essential for the interaction, and a mutant of p53 which is unable to bind E2 is also unable to inhibit HPV DNA replication. Finally, using an inducible system of p53 expression we also show that E2 will complex with p53 in vivo. These results raise the intriguing possibility that p53 may also be involved in HPV DNA replication centres, and also provides explanations for some of the diverse activities reported for the HPV E2 proteins.Keywords
This publication has 50 references indexed in Scilit:
- Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosisThe EMBO Journal, 1997
- Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein.The EMBO Journal, 1997
- A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteinsNucleic Acids Research, 1995
- Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DMA-binding domain bound to its DNA targetNature, 1992
- Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.Genes & Development, 1992
- p53 and DNA polymerase α compete for binding to SV40 T antigenNature, 1987
- Mouse p53 inhibits SV40 origin-dependent DNA replicationNature, 1987
- Identification of Human Papillomavirus Type 18 E6 Polypeptide in Cells Derived from Human Cervical CarcinomasJournal of General Virology, 1987
- Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNANature, 1987
- Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expressionEuropean Journal of Biochemistry, 1986